Literature DB >> 22804876

Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism.

Lisa M Caronia1, Andrew A Dwyer, Douglas Hayden, Francesca Amati, Nelly Pitteloud, Frances J Hayes.   

Abstract

OBJECTIVE: This study examines the physiological impact of a glucose load on serum testosterone (T) levels in men with varying glucose tolerance (GT).
DESIGN: Cross-sectional study. PATIENTS AND METHODS: 74 men (19-74 years, mean 51·4 ± 1·4 years) underwent a standard 75-g oral glucose tolerance test with blood sampling at 0, 30, 60, 90 and 120 min. Fasting serum glucose, insulin, total T (and calculated free T), LH, SHBG, leptin and cortisol were measured.
RESULTS: 57% of the men had normal GT, 30% had impaired GT and 13% had newly diagnosed type 2 diabetes. Glucose ingestion was associated with a 25% decrease in mean T levels (delta = -4·2 ± 0·3 nm, P < 0·0001). T levels remained suppressed at 120 min compared with baseline (13·7 ± 0·6 vs 16·5 ± 0·7 nm, P < 0·0001) and did not differ across GT or BMI. Of the 66 men with normal T levels at baseline, 10 (15%) had levels that decreased to the hypogonadal range (<9·7 nm) at one or more time points. SHBG, LH and cortisol levels were unchanged. Leptin levels decreased from baseline at all time points (P < 0·0001).
CONCLUSIONS: Glucose ingestion induces a significant reduction in total and free T levels in men, which is similar across the spectrum of glucose tolerance. This decrease in T appears to be because of a direct testicular defect, but the absence of compensatory changes in LH suggests an additional central component. Men found to have low nonfasting T levels should be re-evaluated in the fasting state.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22804876     DOI: 10.1111/j.1365-2265.2012.04486.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  19 in total

1.  Oral glucose load and mixed meal feeding lowers testosterone levels in healthy eugonadal men.

Authors:  Thiago Gagliano-Jucá; Zhuoying Li; Karol M Pencina; Yusnie M Beleva; Olga D Carlson; Josephine M Egan; Shehzad Basaria
Journal:  Endocrine       Date:  2018-09-06       Impact factor: 3.633

Review 2.  Diagnosing and managing low serum testosterone.

Authors:  Ana Marcella Rivas; Zachary Mulkey; Joaquin Lado-Abeal; Shannon Yarbrough
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-10

3.  Human metabolome associates with dietary intake habits among African Americans in the atherosclerosis risk in communities study.

Authors:  Yan Zheng; Bing Yu; Danny Alexander; Lyn M Steffen; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2014-05-06       Impact factor: 4.897

Review 4.  Sex steroids and glucose metabolism.

Authors:  Carolyn A Allan
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

5.  Changes in testosterone related to body composition in late midlife: Findings from the 1946 British birth cohort study.

Authors:  David Bann; Frederick C W Wu; Brian Keevil; Hany Lashen; Judith Adams; Rebecca Hardy; Graciela Muniz; Diana Kuh; Yoav Ben-Shlomo; Ken K Ong
Journal:  Obesity (Silver Spring)       Date:  2015-06-05       Impact factor: 5.002

6.  Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.

Authors:  Bruno Lunenfeld; George Mskhalaya; Michael Zitzmann; Stefan Arver; Svetlana Kalinchenko; Yuliya Tishova; Abraham Morgentaler
Journal:  Aging Male       Date:  2015-02-06       Impact factor: 5.892

7.  Testosterone level and risk of type 2 diabetes in men: a systematic review and meta-analysis.

Authors:  Qiu-Ming Yao; Bin Wang; Xiao-Fei An; Jin-An Zhang; Liumei Ding
Journal:  Endocr Connect       Date:  2017-12-12       Impact factor: 3.335

8.  Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes.

Authors:  Entesar Oa El Saghier; Salah E Shebl; Olfat A Fawzy; Ihab M Eltayeb; Lamya Ma Bekhet; Abdelnasser Gharib
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2015-07-19

9.  Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics.

Authors:  Ronald Wiehle; Glenn R Cunningham; Nelly Pitteloud; Jenny Wike; Kuang Hsu; Gregory K Fontenot; Michele Rosner; Andrew Dwyer; Joseph Podolski
Journal:  BJU Int       Date:  2013-07-12       Impact factor: 5.588

10.  Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.

Authors:  Georgios K Dimitriadis; Harpal S Randeva; Saboor Aftab; Asad Ali; John G Hattersley; Sarojini Pandey; Dimitris K Grammatopoulos; Georgios Valsamakis; Georgios Mastorakos; T Hugh Jones; Thomas M Barber
Journal:  Endocrine       Date:  2018-02-02       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.